Overview

Where the power of nature meets the logic of science for the betterment of health.
ChromaDex leverages its complementary business units to discover, acquire, develop and commercialize patented and proprietary ingredient technologies that address the dietary supplement, food, beverage, skin care and pharmaceutical markets. In addition to our ingredient technologies unit, we also have business units focused on natural product fine chemicals, chemistry and analytical testing services, and product regulatory and safety consulting. As a result of our relationships with leading universities and research institutions, we are able to discover and acquire early stage, ingredient technologies that are protected by intellectual property.... More »

Stock Quote
NASDAQ - CDXC
Price$3.77
Change (%)0.00 (0.00%)
Volume42,158
Refresh quote
Real-Time Level 2 Quote
Recent NewsMore »
DateTitle 
08/15/16U.S. FDA issues GRAS No Objection Letter for NIAGEN®
NR, a vitamin B3, affords food and beverage manufacturers a new opportunity to innovate IRVINE, Calif., Aug. 15, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that the U.S. Food and Drug Administration (FDA) has issued a generally recognized as safe (GRAS) No O... 
Printer Friendly Version
08/11/16ChromaDex Reports Record Revenue as Ingredients Sales Climb 83% Compared to Previous Year Period
-Company Reports Record Revenue of $8.8 Million and Operating Income of $371,000- IRVINE, Calif., Aug. 11, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today record revenue for the second quarter ended July 2, 2016.  Results of operations for the three months e... 
Printer Friendly Version
08/10/16Scientists Find Important Clue to Restoring Muscle Function That’s Lost as We Age
Published study in mice points to the potential of a form of vitamin B3 referred to as NR to trigger this regenerative process  IRVINE, Calif., Aug. 10, 2016 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions to dietary supplement, food and beverage, skin care, sports nutrition, and pharmaceutical products, announced today that University of Pennsylvania researchers have uncovered... 
Printer Friendly Version
Upcoming EventsMore »

There are currently no events scheduled.

What's New
Download Documentation2016 Q2 Quarterly Report on Form 10Q
Download DocumentationShareholder Letter
Download Documentation2016 Q1 Quarterly Report on Form 10Q
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Chromadex Corp posts new information to the site. Just enter your e-mail address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.